Cargando…

CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment

Cancer is a genetic disease stemming from genetic and epigenetic mutations and is the second most common cause of death across the globe. Clustered regularly interspaced short palindromic repeats (CRISPR) is an emerging gene-editing tool, acting as a defense system in bacteria and archaea. CRISPR/Ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akram, Fatima, Haq, Ikram ul, Sahreen, Sania, Nasir, Narmeen, Naseem, Waqas, Imitaz, Memoona, Aqeel, Amna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Application of CRISPR Gene Editing in Cancer Research and Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580090/ https://www.ncbi.nlm.nih.gov/pubmed/36254536 http://dx.doi.org/10.1177/15330338221132078

Ejemplares similares

An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its Applications
por: Akram, Fatima, et al.
Publicado: (2022)

In Vivo Visualized Tracking of Tumor-Derived Extracellular Vesicles Using CRISPR-Cas9 System
por: Ye, Yangyang, et al.
Publicado: (2022)

Prospects and challenges of CRISPR/Cas genome editing for the study and control of neglected vector‐borne nematode diseases
por: Zamanian, Mostafa, et al.
Publicado: (2016)

CRISPR guide RNA design for research applications
por: Mohr, Stephanie E., et al.
Publicado: (2016)

One-Step Homology Mediated CRISPR-Cas Editing in Zygotes for Generating Genome Edited Cattle
por: Park, Ki-Eun, et al.
Publicado: (2020)

Expanding the plant genome editing toolbox with recently developed CRISPR–Cas systems
por: Wada, Naoki, et al.
Publicado: (2022)

In vivo HSC prime editing rescues sickle cell disease in a mouse model
por: Li, Chang, et al.
Publicado: (2023)

Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells
por: Vavassori, Valentina, et al.
Publicado: (2023)

CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells
por: Flynn, Rowan, et al.
Publicado: (2015)

DNA-free CRISPR-Cas9 gene editing of wild tetraploid tomato Solanum peruvianum using protoplast regeneration
por: Lin, Choun-Sea, et al.
Publicado: (2022)

Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM
por: Anakok, O.F., et al.
Publicado: (2023)

Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods
por: Chaudhari, Hemangi G., et al.
Publicado: (2020)

Novel Type V-A CRISPR Effectors Are Active Nucleases with Expanded Targeting Capabilities
por: Aliaga Goltsman, Daniela S., et al.
Publicado: (2020)

CRISPR–Cas-mediated transcriptional control and epi-mutagenesis
por: Gardiner, Jason, et al.
Publicado: (2022)

Cas9, Cpf1 and C2c1/2/3―What's next?
por: Nakade, Shota, et al.
Publicado: (2017)

Protoplasts: From Isolation to CRISPR/Cas Genome Editing Application
por: Yue, Jin-Jun, et al.
Publicado: (2021)

Advances in Delivery Mechanisms of CRISPR Gene-Editing Reagents in Plants
por: Laforest, Larissa C., et al.
Publicado: (2022)

Base Editing in Peanut Using CRISPR/nCas9
por: Neelakandan, Anjanasree K., et al.
Publicado: (2022)

CRISPR gene editing to improve crop resistance to parasitic plants
por: Jhu, Min-Yao, et al.
Publicado: (2023)

Strategies for delivery of CRISPR/Cas-mediated genome editing to obtain edited plants directly without transgene integration
por: Kocsisova, Zuzana, et al.
Publicado: (2023)

Enhancing canola breeding by editing a glucosinolate transporter gene lacking natural variation
por: He, Yizhou, et al.
Publicado: (2022)

Mini-Review: Transgenerational CRISPR/Cas9 Gene Editing in Plants
por: Impens, Lennert, et al.
Publicado: (2022)

Optimizing CRISPR/Cas9 Editing of Repetitive Single Nucleotide Variants
por: Usher, Inga, et al.
Publicado: (2022)

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
por: Carlisle, Robert C., et al.
Publicado: (2009)

AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage
por: Binny, Christopher, et al.
Publicado: (2012)

Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells
por: Zhang, Fang, et al.
Publicado: (2007)

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
por: Strati, Paolo, et al.
Publicado: (2021)

Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice
por: Lundgren, Taran S., et al.
Publicado: (2022)

Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
por: Ghione, Paola, et al.
Publicado: (2022)

In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4
por: Wang, Hongjie, et al.
Publicado: (2022)

Transcutaneous ultrasound-mediated gene delivery into canine livers achieves therapeutic levels of factor VIII expression
por: Manson, Megan A., et al.
Publicado: (2022)

CD14(+)/CD31(+) monocytes expanded by UM171 correct hemophilia A in zebrafish upon lentiviral gene transfer of factor VIII
por: Elnaggar, Muhammad, et al.
Publicado: (2022)

Adenine base editor–mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation
por: Hardouin, Giulia, et al.
Publicado: (2023)

Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy
por: von Drygalski, Annette, et al.
Publicado: (2022)

Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing
por: Sun, Zhengxu, et al.
Publicado: (2023)

A comprehensive landscape of transcription profiles and data resources for human leukemia
por: Luo, Mei, et al.
Publicado: (2023)

Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in mice
por: Calabria, Andrea, et al.
Publicado: (2023)

CAR NK-92 cell–mediated depletion of residual TCR(+) cells for ultrapure allogeneic TCR-deleted CAR T-cell products
por: Kath, Jonas, et al.
Publicado: (2023)

Introduction of a second “Green Revolution” mutation into wheat via in planta CRISPR/Cas9 delivery
por: Kumagai, Yuya, et al.
Publicado: (2021)

Methodologies and Challenges for CRISPR/Cas9 Mediated Genome Editing of the Mammalian Brain
por: Nishizono, Hirofumi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_69gjd478phe5a3a9s01klg4r4l